L

Lantheus Holdings
D

LNTH

89.290
USD
-2.61
(-2.84%)
Market Closed
Volume
56,208
EPS
7
Div Yield
-
P/E
15
Market Cap
6,208,051,633
News

Title: Lantheus Holdings

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.